The course provides opportunities to a practice prescribing skills of OAT medications. Four learners are grouped with one facilitator, who is an experienced prescriber, and each simulation session is followed by a debrief.
- Conduct a comprehensive assessment of a patient for the suitability of OAT, including diagnosis for moderate-severe opioid use disorder.
- Initiate patient's treatment with methadone or buprenorphine-naloxone per clinical guideline
- Titrate methadone and buprenorphine-naloxone to a stable dose based on assessment of patient
- Manage OAT based on patient clinical stability during maintenance phase including: take-home doses, missed doses, and relapse events, in a manner that is safe for patient and the community
The simulation learning comprises cases of patients; each includes simulated appointments in different points of time in their treatment. Each learner will have the opportunity to actively participate in three sessions of simulation and observe six other sessions, followed by debrief. The debriefs of the sessions will be led by facilitators and include trainees, peers and simulators.
Certification and Accreditation
- This activity is an Accredited Simulation Activity (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians & Surgeons of Canada, and approved by the University of Toronto.
- This Group Learning program has been certified by the College of Family Physicians of Canada for up to 13.50 Mainpro+ credits. (program ID: 192207)
Affiliation and Partnerships
University of Toronto
Course dates will be announced.